[4-[[3-(2-chlorophenyl)-1-methyl-2-oxo-4H-pyrimido[4,5-d]pyrimidin-7-yl]amino]cyclohexyl]-methylsulfonylazanide
C20H24ClN6O3S- — CID 142058577
Data last refreshed: (MolForge compound catalog, from PubChem)
About [4-[[3-(2-chlorophenyl)-1-methyl-2-oxo-4H-pyrimido[4,5-d]pyrimidin-7-yl]amino]cyclohexyl]-methylsulfonylazanide
[4-[[3-(2-chlorophenyl)-1-methyl-2-oxo-4H-pyrimido[4,5-d]pyrimidin-7-yl]amino]cyclohexyl]-methylsulfonylazanide (PubChem CID 142058577) has the molecular formula C20H24ClN6O3S- and a molecular weight of 463.97 g/mol. Its IUPAC name is [4-[[3-(2-chlorophenyl)-1-methyl-2-oxo-4H-pyrimido[4,5-d]pyrimidin-7-yl]amino]cyclohexyl]-methylsulfonylazanide.
Molecular Properties
| Compound Name | [4-[[3-(2-chlorophenyl)-1-methyl-2-oxo-4H-pyrimido[4,5-d]pyrimidin-7-yl]amino]cyclohexyl]-methylsulfonylazanide |
|---|---|
| PubChem CID | 142058577 |
| Molecular Formula | C20H24ClN6O3S- |
| Molecular Weight | 463.97 g/mol |
| Exact Mass | 463.13 |
| IUPAC Name | [4-[[3-(2-chlorophenyl)-1-methyl-2-oxo-4H-pyrimido[4,5-d]pyrimidin-7-yl]amino]cyclohexyl]-methylsulfonylazanide |
| SMILES | CN1C(=O)N(c2ccccc2Cl)Cc2cnc(NC3CCC([N-]S(C)(=O)=O)CC3)nc21 |
| InChI | InChI=1S/C20H24ClN6O3S/c1-26-18-13(12-27(20(26)28)17-6-4-3-5-16(17)21)11-22-19(24-18)23-14-7-9-15(10-8-14)25-31(2,29)30/h3-6,11,14-15H,7-10,12H2,1-2H3,(H,22,23,24)/q-1 |
| InChIKey | MZZJYCRQSLUBSD-UHFFFAOYSA-N |
| XLogP | 3.76 |
| TPSA | 109.60 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 463.97 |
| LogP ≤ 5 | 3.76 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 142058577 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.